Related Experiment Video
Updated: Jul 18, 2025

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
Published on: September 25, 2021
Review and perspective on bioinformatics tools using machine learning and deep learning for predicting antiviral
Nicolás Lefin1, Lisandra Herrera-Belén2, Jorge G Farias1
1Department of Chemical Engineering, Faculty of Engineering and Science, University of La Frontera, Ave. Francisco Salazar, 01145, Temuco, Chile.
Artificial intelligence (AI) aids in discovering antiviral peptides (AVPs), a promising class of antimicrobial peptides (AMPs) for treating viral infections. This review summarizes current AI-driven tools for predicting AVPs, addressing a gap in antiviral research.
Area of Science:
- Biotechnology
- Bioinformatics
- Computational Biology
Background:
- Viruses pose a significant global health threat, necessitating novel therapeutic strategies.
- Antimicrobial peptides (AMPs) show promise for treating infections, with antiviral peptides (AVPs) specifically targeting viruses.
- Existing research on predicting AMPs using machine learning (ML) and deep learning (DL) is more advanced than that for AVPs.
Purpose of the Study:
- To review and summarize current ML and DL-based tools and methods for predicting antiviral peptides (AVPs).
- To highlight the potential of AVPs as pharmaceutical options for human and animal health.
- To address the scarcity of research tools for AVP prediction.
Main Methods:
- Literature review of AI-based tools and methods for AVP prediction.
- Analysis of ML and DL algorithms applied to peptide sequence data.
- Synthesis of current methodologies in the field of computational antiviral research.
Main Results:
- Identified and summarized various ML and DL tools and methods for AVP prediction.
- Highlighted the growing application of AI in deciphering patterns in amino acid sequences for biological functions.
- Demonstrated the potential of AI in accelerating the discovery of novel antiviral therapeutics.
Conclusions:
- AI, particularly ML and DL, offers powerful approaches for predicting AVPs.
- The development of AVP prediction tools is crucial for advancing antiviral drug discovery.
- Further research in this area can lead to effective pharmaceutical options for viral diseases.
More Related Videos
Related Concept Videos
Leaky Scanning
Microorganisms in Medicine and Therapeutics

